MIP Technologies and Supelco Launch a New Selective SPE Product

MIP Technologies AB and Supelco have announced the launch of a new SupelMIP^TM product for the selective extraction of amphetamine and related drugs.

A simple, fast, selective and highly sensitive SPE product has been developed for trace level determinations in forensic, toxicological and pharmaceutical testing. The SPE phase has been evaluated for amphetamine, methamphetamine, phentermine, MDA, MDMA and MDEA. Recoveries are high and the extracts show minimized ion suppression in urine and oral fluids.

SupelMIP levelled at special forensic applications 

- SupelMIP SPE-Amphetamines expand the SupelMIP product portfolio into the drugs of abuse area. The detection levels are in the low ppt (part per trillion) range, which is far lower than competing extraction phases on the market and makes the SupelMIP product ideal for difficult forensic applications where drug concentrations may be low and sensitivity is critical, says Dr Christine Widstrand, VP Sales and Marketing at MIP Technologies.

An Trinh, Product Manager at Supelco stresses that the new SPE phase provides added value to the customers by being efficiently class selective and allowing for lower limits of quantitation for the confirmation of this common drug of abuse.

For further information visit the MIP technologies website.

Source: Press release, MIP Technologies, 10.01.2008